Cargando…
Regulation of Ferroptosis in Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is the most common lung cancer, which accounts for about 35–40% of all lung cancer patients. Despite therapeutic advancements in recent years, the overall survival time of LUAD patients still remains poor, especially KRAS mutant LUAD. Therefore, it is necessary to further...
Autores principales: | Wei, Xiangyun, Li, Xiaohe, Hu, Shuming, Cheng, Jinke, Cai, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572737/ https://www.ncbi.nlm.nih.gov/pubmed/37834062 http://dx.doi.org/10.3390/ijms241914614 |
Ejemplares similares
-
The RSL3 Induction of KLK Lung Adenocarcinoma Cell Ferroptosis by Inhibition of USP11 Activity and the NRF2-GSH Axis
por: Zhang, Wenlong, et al.
Publicado: (2022) -
NRF2, a Superstar of Ferroptosis
por: Yan, Ruihan, et al.
Publicado: (2023) -
KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4
por: Zhao, Guangyin, et al.
Publicado: (2023) -
Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021) -
Role of Ferroptosis in Lung Diseases
por: Xu, Wenting, et al.
Publicado: (2021)